Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Canada Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20076
20085
20092
20103
20112
20121
20133
20154
20161
20175
20183
20193
20201
20212
20222
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated6
Recruiting3
Unknown status3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
GlaxoSmithKline6
Boehringer Ingelheim5
Pfizer5
Novartis Pharmaceuticals3
University of Alberta3
Ottawa Hospital Research Institute2
Asmacure Ltée1
Dennis Jensen, Ph.D.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive49
Dyspnea5
Bronchitis, Chronic4
Emphysema4
Lung Diseases3
Respiration Disorders3
Asthma2
Bronchiolitis Obliterans Syndrome2
Lung Diseases, Interstitial2
alpha 1-Antitrypsin Deficiency2

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.